Andrew Wicks

7PUBLICATIONS
26CO-AUTHORS
Molecular targetsPharmaceutical delivery technologiesMedical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Mar 03, 2025
The transcriptomic architecture of common cancers reflects synthetic lethal interactions.

Syed Haider, Rachel Brough, Santiago Madera

|Feb 12, 2025
PPP2R1A mutations cause ATR inhibitor sensitivity in ovarian clear cell carcinoma.

James Stewart, Dragomir B Krastev, Rachel Brough

|Jul 27, 2022
Opinion: PARP inhibitors in cancer-what do we still need to know?

Andrew J Wicks, Dragomir B Krastev, Stephen J Pettitt

|Jan 11, 2022
The ubiquitin-dependent ATPase p97 removes cytotoxic trapped PARP1 from chromatin.

Dragomir B Krastev, Shudong Li, Yilun Sun

|Nov 16, 2021
PARP Inhibitors - Trapped in a Toxic Love Affair.

Dragomir B Krastev, Andrew J Wicks, Christopher J Lord

|Nov 09, 2021
Sirtuin inhibition is synthetic lethal with BRCA1 or BRCA2 deficiency.

Ilirjana Bajrami, Callum Walker, Dragomir B Krastev

Pageof 2